Considerations for the optimal use of immunoglobulin

Area of Science:

• Immunology
• Pharmacology

Background:

• Immunoglobulins (IgG) are crucial immune proteins for neutralizing pathogens.
• FDA-approved IgG therapies treat primary immunodeficiency, ITP, Kawasaki disease, and more.
• Off-label IgG use is common in autoimmune disorders.

Purpose of the Study:

• To review the appropriate and optimal use of Immunoglobulin G (IgG) preparations.
• To discuss emerging intravenous and subcutaneous IgG formulations.
• To guide clinicians and payers in selecting IgG products.

Main Methods:

• Expert roundtable panel discussions.
• Comprehensive review of the scientific literature on IgG therapy.
• Analysis of factors influencing IgG product selection.

Main Results:

• IgG has approved indications and frequent off-label applications in autoimmune diseases.
• New IgG formulations offer diverse options impacting patient care and economics.
• Optimal IgG selection necessitates balancing patient preferences, clinical evidence, and healthcare policies.

Conclusions:

• The expanding landscape of IgG therapies requires careful consideration for appropriate use.
• Clinicians and payers must integrate patient preferences, evidence-based guidelines, and policies for optimal IgG selection.
• Balancing efficacy, safety, patient choice, and cost is paramount in IgG therapy management.